Stockscreener 앱 받기
5.31
0.38%
-0.02
시간 외 거래:
5.24
-0.07
-1.32%
Tevogen Bio Holdings Inc 주식(TVGN)의 최신 뉴스
Tevogen Bio Holdings Inc. Announces CIO Mittul Mehta to Speak at Microsoft Fabric Community Conference 2026 on Data Engineering and AI - Quiver Quantitative
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) - Finviz
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community ... - Caledonian Record
Microsoft FabCon puts Tevogen AI chief on two data engineering panels - Stock Titan
Neal Flomenberg sells Tevogen Bio Holdings (TVGN) shares for $6.6k - Investing.com
Tevogen Bio (TVGN) officer sells 972 shares to cover tax obligations - Stock Titan
Tevogen reports performance advancements for Tevogen.AI platform - TipRanks
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization - The Globe and Mail
Tevogen Bio Advances AI Drug Development Platform with Improved Predictive Accuracy for Target Identification - Quiver Quantitative
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics ... - Bluefield Daily Telegraph
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure - The Manila Times
Tevogen.AI Reports Advancements in PredicTcell Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure - 富途牛牛
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform - Finviz
Wall Street Recap: Is Tevogen Bio Holdings Inc Equity Warrant undervalued by DCF analysisEarnings Overview Report & Real-Time Market Trend Scan - baoquankhu1.vn
Tevogen Bio Holdings Inc. is considering the acquisition of Sciometrix and Clinicus platforms to enhance its monitoring capabilities for Long Covid. - Bitget
Tevogen Bio Accelerates Development of TVGN 489 for Long COVID with New Leadership and Strategic Initiatives - Quiver Quantitative
Long COVID ‘clinical emergency’: Tevogen develops T-cell therapy for 65% of U.S. - Stock Titan
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment - GlobeNewswire
Tevogen Bio Holdings Inc Share Price USD0.0001 - Hargreaves Lansdown
Tevogen appoints interim leaders across core business verticals - TipRanks
Tevogen Bio Holdings Inc. Appoints Interim Leaders to Drive Diversified Growth Strategy - Quiver Quantitative
Tevogen Names Leadership Team to Execute Diversified Growth Strategy - The Globe and Mail
Free cash flow of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Total liabilities & shareholders' equities of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Total debt of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Tevogen Bio Holdings Inc. Cash Flow – FWB:G280 - TradingView
Tevogen Bio Holdings Inc. Balance Sheet – FWB:G280 - TradingView
Total common shares outstanding of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Operating income of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Total operating expenses of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
After tax other income/expense of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Net current asset value per share of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Enterprise value to EBITDA ratio of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Diluted earnings per share (diluted EPS) of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Price to cash flow ratio of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Non-controlling/minority interest of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Gross profit of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Diluted net income available to common stockholders of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Free cash flow of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Discontinued operations of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Operating income of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Operating expenses (excl. COGS) of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Total operating expenses of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Total revenue of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
EBITDA of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Non-controlling/minority interest of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
After tax other income/expense of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Tevogen Bio Holdings Inc. Statistics – FWB:G280 - TradingView
Number of employees of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Tevogen Bio Holdings Inc. Earnings and Revenue – FWB:G280 - TradingView
Tevogen Bio Holdings Inc. Income Statement – FWB:G280 - TradingView
Basic earnings per share (basic EPS) of Tevogen Bio Holdings Inc. – FWB:G280 - TradingView
Market Review: Is Tevogen Bio Holdings Inc Equity Warrant undervalued by DCF analysis - baoquankhu1.vn
Tevogen Bio Holdings Inc. Revenue Breakdown – TRADEGATE:G280 - TradingView
Price to sales ratio of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Long term debt to total equity ratio of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Operating cash flow per share of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Total common shares outstanding of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Price to cash flow ratio of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
CapEx per share of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Gross margin % of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Tangible book value per share of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Asset turnover of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Tevogen Bio Holdings Inc. Earnings and Revenue – TRADEGATE:G280 - TradingView
Enterprise value of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
EBIT per share of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Debt to equity ratio of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Tevogen Bio Holdings Inc. Financial Statements – TRADEGATE:G280 - TradingView
Price to earnings ratio of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Free float of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Net income of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
Number of employees of Tevogen Bio Holdings Inc. – TRADEGATE:G280 - TradingView
1.20%
0.06%
자본화:
|
볼륨(24시간):